Back to Search
MANI KAVURU, MD
MD
Pulmonary Disease Physician
NPI: 1962486357Individual
Specialties, Licenses & Credentials
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
200501043(NC)
Pulmonary Disease PhysicianPrimary
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
200501043(NC)MD440719(PA)
Research & Publications (20)
Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis.
PMID 10764303·Am J Respir Crit Care Med·2000
5-case
Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation.
PMID 19395578·Chest·2009
4-observational
A novel 1,25-dihydroxyvitamin D-activin A pathway in human alveolar macrophages is dysfunctional in patients with pulmonary alveolar proteinosis (PAP).
PMID 18803071·Autoimmunity·2009
7-preclinical
Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory response.
PMID 19380830·J Immunol·2009
7-preclinical
Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
PMID 19561506·Curr Opin Pulm Med·2009
6-review
Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial.
PMID 18256069·Eur Respir J·2008
2-rct
ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.
PMID 17848583·J Lipid Res·2007
7-preclinical
Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health.
PMID 17189324·Am J Physiol Lung Cell Mol Physiol·2007
7-preclinical
Control of airway inflammation maintained at a lower steroid dose with 100/50 microg of fluticasone propionate/salmeterol.
PMID 16815137·J Allergy Clin Immunol·2006
2-rct
An open-label trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis.
PMID 16840407·Chest·2006
3-trial
Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement.
PMID 16840744·Am J Respir Crit Care Med·2006
3-trial
Depressed peroxisome proliferator-activated receptor gamma (PPargamma) is indicative of severe pulmonary sarcoidosis: possible involvement of interferon gamma (IFN-gamma).
PMID 17937104·Sarcoidosis Vasc Diffuse Lung Dis·2006
8-other
Omalizumab dosing via the recommended card versus use of the published formula.
PMID 16522477·J Allergy Clin Immunol·2006
8-other
Human antibodies for immunotherapy development generated via a human B cell hybridoma technology.
PMID 16505368·Proc Natl Acad Sci U S A·2006
7-preclinical
Suppression of activin A in autoimmune lung disease associated with anti-GM-CSF.
PMID 16337108·J Autoimmun·2006
8-other
Comparison of sarcoidosis phenotypes among affected African-American siblings.
PMID 16963686·Chest·2006
4-observational
Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
PMID 16275889·J Leukoc Biol·2006
7-preclinical
Estimating FVC from FEV2 and FEV3: assessment of a surrogate spirometric parameter.
PMID 16162718·Chest·2005
4-observational
An inverse relationship between peroxisome proliferator-activated receptor gamma and allergic airway inflammation in an allergen challenge model.
PMID 16312170·Ann Allergy Asthma Immunol·2005
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 834 WALNUT ST, SUITE 650
PHILADELPHIA, PA 19107 - Phone
- (215) 955-5161
Quick Facts
- NPI
- 1962486357
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 3
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile